VOR
VOR
NASDAQ · Biotechnology

Vor Biopharma Inc

$19.56
-0.42 (-2.10%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +77.6% upside
Low Target $25.90
Average Target $34.74
High Target $38.60
Current Price $19.56
Current
$19.56
Target
$34.74
$25.90 $34.74 avg $38.60
Scenario Analysis
Bear Case
$25.90
32.4%
Low target
Base Case
$34.74
+77.6%
Avg target
Bull Case
$38.60
+97.3%
High target
Risk/Reward
3.0x
Highly favorable
Price in Context
52-Week High
$26.00
-24.8% from high
52-Week Low
$6.50
+200.9% from low
Target vs 52W High
$34.74
+33.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%